Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.71 USD
Change Today +0.03 / 4.41%
Volume 218.4K
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael R. Moynihan Ph.D.

Vice President of Research & Development,22nd Century Group, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Dr. Michael R. Moynihan, Ph.D. has been Vice President of Research & Development at 22nd Century Limited, LLC and 22nd Century Group, Inc. since March 2007 and March 2011 respectively. Dr. Moynihan has been a Consultant at 22nd Century Limited, LLC since 1999. From 2001 to 2006, Dr. Moynihan served as the Director of Biotechnology Development at Fundación Chile and from 1995 to 2000 as Senior Project Director at InterLink Biotechnologies LLC. He previously served as ...

Read Full Background

Corporate Headquarters*

9530 Main Street
Clarence, New York 14031

United States

Phone: 716-270-1523
Fax: 716-877-3064

Board Members Memberships*

There is no Board Members Memberships data available.


Harvard University
Master's Degree
Harvard University
Brown University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$185,000

Stock Options*

Restricted Stock Awards$361,600
All Other Compensation$67,818
Exercisable Options175,000
Total Number of Options175,000

Total Compensation*

Total Annual Cash Compensation$252,818
Total Short Term Compensation$185,000
Other Long Term Compensation$429,418
Total Calculated Compensation$614,418
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XXII:US $0.71 USD +0.03


Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Joseph C. Papa Chairman, Chief Executive Officer and President
Perrigo Company Public Limited Company
Alison J. Cooper BSC, ACAChief Executive Officer, Executive Director and Member of Chief Executives Committee
Imperial Tobacco Group PLC
2.2M GBP
Susan M. Cameron Chief Executive Officer, President, Director and President of Rai Services Company
Reynolds American Inc.
André Calantzopoulos Chief Executive Officer and Director
Philip Morris International, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 22ND CENTURY GROUP INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at